Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells f...

Full description

Bibliographic Details
Main Authors: Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen
Format: Article
Language:English
Published: Innovative Healthcare Institute 2023-05-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-22-27
_version_ 1797776370732892160
author Zainab Fatima
Abdulrahman Abonofal
Bettzy Stephen
author_facet Zainab Fatima
Abdulrahman Abonofal
Bettzy Stephen
author_sort Zainab Fatima
collection DOAJ
description Immune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells for nutrients in the tumor microenvironment and generates by-products harmful for immune cell differentiation and growth. In this review, we discuss these metabolic alterations and the current therapeutic strategies to mitigate these alterations to metabolic pathways that can be used in combination with checkpoint blockade to offer a new path forward in cancer management.
first_indexed 2024-03-12T22:50:00Z
format Article
id doaj.art-4c14fec289804f55a76bcb6bc1c64cc5
institution Directory Open Access Journal
issn 2666-2345
2590-017X
language English
last_indexed 2024-03-12T22:50:00Z
publishDate 2023-05-01
publisher Innovative Healthcare Institute
record_format Article
series Journal of Immunotherapy and Precision Oncology
spelling doaj.art-4c14fec289804f55a76bcb6bc1c64cc52023-07-20T14:50:11ZengInnovative Healthcare InstituteJournal of Immunotherapy and Precision Oncology2666-23452590-017X2023-05-01629110210.36401/JIPO-22-27i2590-017X-6-2-91Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint InhibitorsZainab Fatima0Abdulrahman Abonofal1Bettzy Stephen21 Department of Hospice and Palliative Care, Virginia Commonwealth University, Richmond, VA, USA2 Department of Medicine, Section of Hematology/Oncology, West Virginia University, Morgantown, WV, USA3 Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAImmune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells for nutrients in the tumor microenvironment and generates by-products harmful for immune cell differentiation and growth. In this review, we discuss these metabolic alterations and the current therapeutic strategies to mitigate these alterations to metabolic pathways that can be used in combination with checkpoint blockade to offer a new path forward in cancer management.https://jipo.org/doi/pdf/10.36401/JIPO-22-27immune checkpoint inhibitorsglucose metabolismamino acid metabolismlipid metabolismadenosine pathway
spellingShingle Zainab Fatima
Abdulrahman Abonofal
Bettzy Stephen
Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
Journal of Immunotherapy and Precision Oncology
immune checkpoint inhibitors
glucose metabolism
amino acid metabolism
lipid metabolism
adenosine pathway
title Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
title_full Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
title_fullStr Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
title_full_unstemmed Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
title_short Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
title_sort targeting cancer metabolism to improve outcomes with immune checkpoint inhibitors
topic immune checkpoint inhibitors
glucose metabolism
amino acid metabolism
lipid metabolism
adenosine pathway
url https://jipo.org/doi/pdf/10.36401/JIPO-22-27
work_keys_str_mv AT zainabfatima targetingcancermetabolismtoimproveoutcomeswithimmunecheckpointinhibitors
AT abdulrahmanabonofal targetingcancermetabolismtoimproveoutcomeswithimmunecheckpointinhibitors
AT bettzystephen targetingcancermetabolismtoimproveoutcomeswithimmunecheckpointinhibitors